Lilly's cheap weight-loss drugs hurt Hims stock #LLY #HIMS #GLP1 [prLtKqzn1]

Lilly's cheap weight-loss drugs hurt Hims stock #LLY #HIMS #GLP1 [prLtKqzn1]

Lilly has announced price reductions for the two lowest doses of its obesity drug Zepbound (tirzepatide) when purchased through its direct-to-consumer channel, LillyDirect. The new prices for 2.5mg and 5.0mg doses will be at least 50% lower than the list prices of other GLP-1 obesity medications, but only for self-pay customers and not for insurance-covered doses. This move follows a similar strategy by Hims & Hers, who in May announced plans to offer discounted compounded versions of semaglutide -- which is also sold as the type 2 diabetes med Ozempic -- starting at $199 a month. Hims is also offering a $79 a month plan for an oral version of semaglutide. That is also known as Novo's diabetes pill Rybelsus.

Related Videos :

• NEW Titan Series Products by Mike O'Hearn [H1WVj7sSK]
• Medical Weight Loss Program - Down 60lbs! [VQMA9mZD4]
• Food you can eat on the Golo Diet [rCU5rpgDZ]
• LAZ ALONSO "THE MYSTERIES OF LAURA" [VL6YqzIh2]
• Role of GLP-1 Receptor Agonists for Weight Loss [echYA06dQ]